Metaphore: systematizing molecular mimicry

Flagship-founded Metaphore, launched May 16, is developing therapeutics that mimic natural molecular interactions, but have improved biophysical features.

Metaphore Biotechnologies Inc. started in stealth in 2021 with $50 million, under Flagship Pioneering’s incubation model. Lovisa Afzelius, origination partner at Flagship and co-founder and CEO at Metaphore, said they asked themselves, “What if we could mimic a molecular interface in a programmable way?”...